Rocket, Lab’s

Rocket Lab’s Neutron Conundrum: Why a Record $2.2 Billion Backlog Hasn’t Stopped the Stock’s 55% Slide

Published on 07/18/2026 at 19:32 | Redaktion boerse-global.de

Rocket Lab's strategic wins—$8B Iridium acquisition, Space Force mission—fail to lift stock as Neutron rocket delays and cash burn spook investors, shares down 55% from highs.

Rocket Lab's $8B Iridium Deal and Neutron Rocket Delays: Stock Plunges 55%
Rocket Lab USA Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Rocket Lab is executing a transformation few companies in the space sector have attempted. The company has locked down an $8 billion acquisition of Iridium Communications, won a rapid-response mission for the US Space Force, and built a backlog of orders worth $2.2 billion — a 106% jump from a year earlier. Yet the stock has shed 55% of its value since touching an all-time high of $151 in late May, closing last week at $67.62. The disconnect between strategic progress and market sentiment is glaring, and it all comes down to one piece of hardware: the Neutron rocket.

The Iridium deal, finalised on 29 June, gives Rocket Lab a fully operational low-Earth-orbit satellite network and globally harmonised L?band spectrum. The acquisition, valued at $54 per share in cash and stock for a total enterprise value of roughly $8 billion, is expected to close by mid?2027. Analysts at Citizens and Roth Capital promptly raised their price targets to $130, calling the move transformative. Citizens analyst Trevor Walsh argued the deal “accelerates the push into higher-value space applications” and creates a vertically integrated platform spanning launch services, spacecraft manufacturing, spectrum rights, and in?orbit communications. Roth’s Suji Desilva echoed that view, positioning Rocket Lab as a full?spectrum space infrastructure provider.

But investors have fixated on a more immediate risk: Neutron itself. The reusable medium-lift rocket, designed to take on SpaceX in the payload sweet spot, has suffered a series of setbacks. A fuel tank burst in January added to an earlier schedule slip, pushing the first flight from the original first?quarter target to no earlier than the fourth quarter of 2026 — the second delay in just over a year. Rocket Lab did complete a full hot?fire test of the vacuum?optimised AVac engine on 13 July, a milestone it described as on track, but the market remains unpersuaded. The stock’s slide accelerated sharply after Piper Sandler analyst Alexander Potter initiated coverage with a neutral rating and an $83 price target, noting a preference for a competitor. The stock tumbled more than 12% on 16 July, touching its lowest level since 13 April.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Technical indicators reinforce the bearish mood. The 14?day relative strength index sits at 30.1, deep in oversold territory, while the 50?day moving average of $107.37 looms far above the current price. The RSI reading typically flags an exaggerated sell?off, but in a capital?intensive growth sector like space, steep corrections are common once the costs of expansion become visible. Rocket Lab is funding the Iridium acquisition, developing an entirely new rocket, and scaling its Electron launch business simultaneously — a cash?burning phase that demands patience Wall Street is currently unwilling to extend.

Not all signals are negative. The VICTUS?HAZE mission for the US Space Force, launched on 19 June under 17 hours from notification with complex orbital rendezvous manoeuvres, demonstrated a rapid?response capability that sets Rocket Lab apart from conventional launch providers. The company reported a record first?quarter revenue of $200 million in May and added 31 new Electron and HASTE contracts alongside five dedicated Neutron missions, pushing the total mission backlog past 70. The global space?technology market is forecast to nearly double from an estimated $551.2 billion in 2026 to $1.08 trillion by 2035, providing ample runway for a company that can execute.

The immediate catalysts are clear. Neutron’s next testing milestone will be the single most important determinant of whether the oversold condition marks a genuine floor or merely a pause in a longer downtrend. Iridium is scheduled to report second?quarter results on 22 July, though the ongoing takeover means no conference call will be held — results will appear directly on the investor relations page. For Rocket Lab, every step of Neutron development is now a make?or?break event in a story where the strategic vision has never been bigger, but the execution risk has never been more visible.

Ad

Rocket Lab USA Stock: New Analysis - 18 July

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US7731221062 | ROCKET | boerse | 69797994 |